Fat/water ratios measured with diffuse reflectance spectroscopy to detect breast tumor boundaries

Recognition of the tumor during breast-conserving surgery (BCS) can be very difficult and currently a robust method of margin assessment for the surgical setting is not available. As a result, tumor-positive margins, which require additional treatment, are not found until histopathologic evaluation. With diffuse reflectance spectroscopy (DRS), tissue can be characterized during surgery based on optical parameters that are related to the tissue morphology and composition. Here we investigate which optical parameters are able to detect tumor in an area with a mixture of benign and tumor tissue and hence which parameters are most suitable for intra-operative margin assessment. DRS spectra (400–1600 nm) were obtained from 16 ex vivo lumpectomy specimens from benign, tumor border, and tumor tissue. One mastectomy specimen was used with a custom-made grid for validation purposes. The optical parameter related to the absorption of fat and water (F/W-ratio) in the extended near-infrared wavelength region (~1000–1600 nm) provided the best discrimination between benign and tumor sites resulting in a sensitivity and specificity of 100 % (excluding the border sites). Per patient, the scaled F/W-ratio gradually decreased from grossly benign tissue towards the tumor in 87.5 % of the specimens. In one test case, based on a predefined F/W-ratio for boundary tissue of 0.58, DRS produced a surgical resection plane that nearly overlapped with a 2-mm rim of benign tissue, 2 mm being the most widely accepted definition of a negative margin. The F/W-ratio provided excellent discrimination between sites clearly inside or outside the tumor and was able to detect the border of the tumor in one test case. This work shows the potential for DRS to guide the surgeon during BCS.

[1]  B. Wilson,et al.  A diffusion theory model of spatially resolved, steady-state diffuse reflectance for the noninvasive determination of tissue optical properties in vivo. , 1992, Medical physics.

[2]  N K Aaronson,et al.  Quality of life of early-stage breast cancer patients treated with radical mastectomy or breast-conserving procedures: results of EORTC Trial 10801. The European Organization for Research and Treatment of Cancer (EORTC), Breast Cancer Co-operative Group (BCCG). , 1998, European journal of cancer.

[3]  S. Harms,et al.  Assessing margin status. , 1999, Surgical oncology.

[4]  L Fallowfield,et al.  Comparison of psychological aspects and patient satisfaction following breast conserving surgery, simple mastectomy and breast reconstruction. , 2000, European journal of cancer.

[5]  Richard Sylvester,et al.  Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. , 2000, Journal of the National Cancer Institute.

[6]  S J Schnitt,et al.  Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: influence of margin status and systemic therapy on local recurrence. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  S. Lakhani,et al.  Diagnosis of breast cancer using elastic-scattering spectroscopy: preliminary clinical results. , 2000, Journal of biomedical optics.

[8]  Jong-Hyeon Jeong,et al.  Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. , 2002, The New England journal of medicine.

[9]  Umberto Veronesi,et al.  Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. , 2002, The New England journal of medicine.

[10]  S. Singletary,et al.  Standard for Breast Conservation Therapy in the Management of Invasive Breast Carcinoma , 2002, CA: a cancer journal for clinicians.

[11]  S. Singletary Scientific paper Surgical margins in patients with early-stage breast cancer treated with breast conservation therapy , 2002 .

[12]  B. Goh,et al.  Eighteen‐year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy , 2004, Cancer.

[13]  Nirmala Ramanujam,et al.  Diagnosis of breast cancer using diffuse reflectance spectroscopy: Comparison of a Monte Carlo versus partial least squares analysis based feature extraction technique , 2006, Lasers in surgery and medicine.

[14]  Kelly K. Hunt,et al.  Role for Intraoperative Margin Assessment in Patients Undergoing Breast-Conserving Surgery , 2007, Annals of Surgical Oncology.

[15]  S. Masood,et al.  Use of imprint cytology for assessment of surgical margins in lumpectomy specimens of breast cancer patients , 2007, Diagnostic cytopathology.

[16]  T. Breslin,et al.  In vivo Margin Assessment During Partial Mastectomy Breast Surgery Using Raman Spectroscopy , 2007 .

[17]  L. Newman,et al.  Predictors of Re-excision among Women Undergoing Breast-Conserving Surgery for Cancer , 2008, Annals of Surgical Oncology.

[18]  M. Morrow Margins in breast-conserving therapy: have we lost sight of the big picture? , 2008, Expert review of anticancer therapy.

[19]  Anita Mahadevan-Jansen,et al.  Comparison of autofluorescence, diffuse reflectance, and Raman spectroscopy for breast tissue discrimination. , 2008, Journal of biomedical optics.

[20]  Zoya I. Volynskaya,et al.  Diagnosing breast cancer using diffuse reflectance spectroscopy and intrinsic fluorescence spectroscopy. , 2008, Journal of biomedical optics.

[21]  Nirmala Ramanujam,et al.  Diagnosis of breast cancer using fluorescence and diffuse reflectance spectroscopy: a Monte-Carlo-model-based approach. , 2008, Journal of biomedical optics.

[22]  S. Ratcliffe,et al.  Analysis of multi-level correlated data in the framework of generalized estimating equations via xtmultcorr procedures in Stata and qls functions in Matlab , 2009 .

[23]  Reshma Jagsi,et al.  What is an Adequate Margin for Breast-Conserving Surgery? Surgeon Attitudes and Correlates , 2010, Annals of Surgical Oncology.

[24]  Paola Taroni,et al.  Diffuse optical spectroscopy of breast tissue extended to 1100 nm. , 2009, Journal of biomedical optics.

[25]  Rami Nachabé,et al.  Estimation of biological chromophores using diffuse optical spectroscopy: benefit of extending the UV-VIS wavelength range to include 1000 to 1600 nm , 2010, Biomedical optics express.

[26]  Nimmi Ramanujam,et al.  Optical breast cancer margin assessment: an observational study of the effects of tissue heterogeneity on optical contrast , 2010, Breast Cancer Research.

[27]  J. Sandbank,et al.  Diagnostic performance of a novel device for real-time margin assessment in lumpectomy specimens. , 2010, The Journal of surgical research.

[28]  I. Yeh,et al.  Intraoperative evaluation of margin status: How much is enough? , 2010 .

[29]  C. Laronga,et al.  Attaining Negative Margins in Breast-Conservation Operations: Is There a Consensus among Breast Surgeons? , 2010 .

[30]  Forough Farrokhyar,et al.  Technical factors, surgeon case volume and positive margin rates after breast conservation surgery for early-stage breast cancer. , 2010, Canadian journal of surgery. Journal canadien de chirurgie.

[31]  M. B. van der Mark,et al.  Estimation of lipid and water concentrations in scattering media with diffuse optical spectroscopy from 900 to 1,600 nm. , 2010, Journal of biomedical optics.

[32]  Torre M Bydlon,et al.  Optical Assesssment of Tumor Resection Margins in the Breast , 2010, IEEE Journal of Selected Topics in Quantum Electronics.

[33]  Seema A Khan,et al.  Optimal surgical treatment of breast cancer: Implications for local control and survival , 2010, Journal of surgical oncology.

[34]  Les Irwig,et al.  Meta-analysis of the impact of surgical margins on local recurrence in women with early-stage invasive breast cancer treated with breast-conserving therapy. , 2010, European journal of cancer.

[35]  M. Sabel Surgical considerations in early-stage breast cancer: lessons learned and future directions. , 2011, Seminars in radiation oncology.

[36]  Matthew D. Keller,et al.  Development of a spatially offset Raman spectroscopy probe for breast tumor surgical margin evaluation. , 2011, Journal of biomedical optics.

[37]  H. Feigelson,et al.  Variability in reexcision following breast conservation surgery. , 2012, JAMA.

[38]  Lee G. Wilke,et al.  Intraoperative Imprint Cytology and Frozen Section Pathology for Margin Assessment in Breast Conservation Surgery: A Systematic Review , 2012, Annals of Surgical Oncology.

[39]  Benno H. W. Hendriks,et al.  Diffuse reflectance spectroscopy: towards clinical application in breast cancer , 2012, Breast Cancer Research and Treatment.

[40]  M. Trivella,et al.  Reoperation rates after breast conserving surgery for breast cancer among women in England: retrospective study of hospital episode statistics , 2012, BMJ : British Medical Journal.

[41]  Venkataramanan Krishnaswamy,et al.  Spectral discrimination of breast pathologies in situ using spatial frequency domain imaging , 2013, Breast Cancer Research.

[42]  J. Quincy Brown,et al.  Optical Spectral Surveillance of Breast Tissue Landscapes for Detection of Residual Disease in Breast Tumor Margins , 2013, PloS one.

[43]  Thomas Frazier,et al.  A Randomized Prospective Study of Lumpectomy Margin Assessment with Use of MarginProbe in Patients with Nonpalpable Breast Malignancies , 2014, Annals of Surgical Oncology.

[44]  Seema A Khan,et al.  Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[45]  P. Macaskill,et al.  The Association of Surgical Margins and Local Recurrence in Women with Early-Stage Invasive Breast Cancer Treated with Breast-Conserving Therapy: A Meta-Analysis , 2014, Annals of Surgical Oncology.